home / stock / mgen / mgen news


MGEN News and Press, Miragen Therapeutics Inc. From 08/20/19

Stock Information

Company Name: Miragen Therapeutics Inc.
Stock Symbol: MGEN
Market: NASDAQ

Menu

MGEN MGEN Quote MGEN Short MGEN News MGEN Articles MGEN Message Board
Get MGEN Alerts

News, Short Squeeze, Breakout and More Instantly...

MGEN - SRPT, SE, ELAN among premarket losers

Synlogic (NASDAQ: SYBX )  -25%  in reaction to its decision to terminate development of SYNB1020 for the treatment of hyperammonemia. More news on: Synlogic, Inc., Sarepta Therapeutics, Inc., Fabrinet, Stocks on the move, Read more ...

MGEN - miRagen Therapeutics to Present a Corporate Overview at the Robert W. Baird & Co. 2019 Global Healthcare Conference

BOULDER, Colo., Aug. 15, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, announced today that William S. Marshall, Ph.D., President and Chief Exec...

MGEN - miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare Conference

BOULDER, Colo., Aug. 12, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, announced today that William S. Marshall, Ph.D., President and Chief Exec...

MGEN - miRagen Therapeutics' (MGEN) CEO Bill Marshall on Q2 2019 Results - Earnings Call Transcript

miRagen Therapeutics, Inc. (MGEN) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Dan Ferry – Managing Director-LifeSci Advisors, LLC Bill Marshall – President and Chief Executive Officer Jason Leverone – Chief Financial Office...

MGEN - Miragen Therapeutics EPS beats by $0.07, beats on revenue

Miragen Therapeutics (NASDAQ: MGEN ): Q2 GAAP EPS of -$0.29 beats by $0.07 . More news on: Miragen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

MGEN - miRagen Reports Second Quarter 2019 Results; Regains Global Rights to MRG-110 and Announces Corporate Restructuring

miRagen to regain global rights to MRG-110 after Servier provides notice of portfolio realignment; expects to announce Phase 1 data during the second half of 2019 Company anticipates reporting primary endpoint data from the SOLAR clinical trial in the first half of 2021 Restructurin...

MGEN - Miragen down 20% ahead of Q2 report

Thinly traded nano cap Miragen Therapeutics ( MGEN -19.8% ) slumps on almost triple normal volume ahead of its Q2 results to be released after the close tomorrow. More news on: Miragen Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

MGEN - ALLK, ADNT, GSKY and PODD among midday movers

Gainers:  EverQuote (NASDAQ: EVER ) +47% . NeoPhotonics Corporation (NYSE: NPTN ) +27% . Invacare Corporation (NYSE: IVC ) +23% . Adient plc (NYSE: ADNT ) +23% . Ducommun Incorporated (NYSE: DCO ) +22% . Insulet Corporation (NASDAQ: PODD ) +19% . Greenlight Capital Re (NASDAQ: G...

MGEN - Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7th

BOULDER, Colo., July 24, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, will host a conference call on Wednesday, August 7 th , at 4:30 p.m. ET t...

MGEN - Microcaps mostly among midday movers

Gainers:  Immuron (NASDAQ: IMRN ) +81% . Blue Apron Holdings (NYSE: APRN ) +49% . Moxian (NASDAQ: MOXC ) +35% . GAIN Capital Holdings (NYSE: GCAP ) +32% . Lonestar Resources (NASDAQ: LONE ) +19% . AVROBIO (NASDAQ: AVRO ) +17% . Dolphin Entertainment (NASDAQ: DLPN ) +16% . Bio-P...

Previous 10 Next 10